US Stock MarketDetailed Quotes

Krystal Biotech (KRYS)

Watchlist
  • 291.390
  • +2.265+0.78%
Trading Jan 23 10:46 ET
8.45BMarket Cap43.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Krystal Biotech (KRYS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
16.65%97.8M
36.65%96.04M
94.88%88.18M
473.02%290.52M
116.26%91.14M
879.91%83.84M
70.28M
45.25M
50.7M
42.14M
Operating revenue
16.65%97.8M
36.65%96.04M
94.88%88.18M
473.02%290.52M
116.26%91.14M
879.91%83.84M
--70.28M
--45.25M
--50.7M
--42.14M
Cost of revenue
-36.22%4.26M
19.24%7.17M
107.85%5.03M
548.38%20.06M
72.38%4.95M
2,897.31%6.68M
6.01M
2.42M
3.09M
2.87M
Gross profit
21.23%93.54M
38.28%88.88M
94.15%83.16M
468.12%270.45M
119.47%86.19M
825.92%77.16M
64.28M
42.83M
47.61M
39.27M
Operating expense
23.65%52.16M
14.72%49.57M
26.92%46.98M
15.48%167.26M
24.17%44.87M
22.90%42.19M
13.56%43.21M
1.91%37.02M
20.50%144.83M
3.92%36.13M
Selling and administrative expenses
31.06%37.58M
27.27%35.16M
25.58%32.72M
15.53%113.69M
26.58%31.35M
21.00%28.67M
6.65%27.63M
8.42%26.06M
26.59%98.4M
3.05%24.76M
Research and development costs
7.94%14.59M
-7.53%14.41M
30.10%14.26M
15.38%53.57M
18.92%13.52M
27.12%13.51M
28.32%15.58M
-10.83%10.96M
9.35%46.43M
5.86%11.37M
Operating profit
18.31%41.37M
86.59%39.31M
522.03%36.18M
206.14%103.2M
1,216.83%41.32M
234.54%34.97M
155.37%21.07M
116.01%5.82M
19.11%-97.23M
109.02%3.14M
Net non-operating interest income expense
-9.65%6.59M
-0.15%7.47M
-2.57%7.42M
31.10%29.66M
-3.07%7.29M
8.26%7.3M
54.59%7.48M
116.00%7.62M
333.33%22.62M
176.54%7.52M
Non-operating interest income
-9.65%6.59M
-0.15%7.47M
----
31.10%29.66M
--7.29M
--7.3M
54.59%7.48M
116.00%7.62M
333.33%22.62M
----
Total other finance cost
----
----
2.57%-7.42M
----
----
-8.84%-7.34M
----
---7.62M
----
----
Other net income (expense)
-142.86%-37.5M
0
-112.50%-12.5M
-12.5M
0.00%-12.5M
450.00%87.5M
0
Special income (charges)
--0
--0
--0
-142.86%-37.5M
--0
-112.50%-12.5M
---12.5M
0.00%-12.5M
450.00%87.5M
--0
-Less:Other special charges
----
----
----
142.86%37.5M
--0
112.50%12.5M
--12.5M
0.00%12.5M
-450.00%-87.5M
--0
Income before tax
61.13%47.97M
191.52%46.78M
4,577.79%43.6M
639.37%95.36M
356.13%48.61M
-63.13%29.77M
148.31%16.05M
102.06%932K
109.21%12.9M
133.25%10.66M
Income tax
-1,312.75%-31.4M
1,669.81%8.44M
7.86M
215.37%6.2M
59.34%3.13M
2.59M
477K
0
1.97M
1.97M
Net income
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
Net income continuous Operations
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
Minority interest income
Net income attributable to the parent company
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
Basic earnings per share
188.42%2.74
146.30%1.33
4,033.33%1.24
680.00%3.12
393.75%1.58
-67.01%0.95
143.20%0.54
101.70%0.03
107.29%0.4
125.60%0.32
Diluted earnings per share
192.31%2.66
143.40%1.29
3,900.00%1.2
669.23%3
390.32%1.52
-67.38%0.91
142.40%0.53
101.70%0.03
107.10%0.39
124.80%0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 16.65%97.8M36.65%96.04M94.88%88.18M473.02%290.52M116.26%91.14M879.91%83.84M70.28M45.25M50.7M42.14M
Operating revenue 16.65%97.8M36.65%96.04M94.88%88.18M473.02%290.52M116.26%91.14M879.91%83.84M--70.28M--45.25M--50.7M--42.14M
Cost of revenue -36.22%4.26M19.24%7.17M107.85%5.03M548.38%20.06M72.38%4.95M2,897.31%6.68M6.01M2.42M3.09M2.87M
Gross profit 21.23%93.54M38.28%88.88M94.15%83.16M468.12%270.45M119.47%86.19M825.92%77.16M64.28M42.83M47.61M39.27M
Operating expense 23.65%52.16M14.72%49.57M26.92%46.98M15.48%167.26M24.17%44.87M22.90%42.19M13.56%43.21M1.91%37.02M20.50%144.83M3.92%36.13M
Selling and administrative expenses 31.06%37.58M27.27%35.16M25.58%32.72M15.53%113.69M26.58%31.35M21.00%28.67M6.65%27.63M8.42%26.06M26.59%98.4M3.05%24.76M
Research and development costs 7.94%14.59M-7.53%14.41M30.10%14.26M15.38%53.57M18.92%13.52M27.12%13.51M28.32%15.58M-10.83%10.96M9.35%46.43M5.86%11.37M
Operating profit 18.31%41.37M86.59%39.31M522.03%36.18M206.14%103.2M1,216.83%41.32M234.54%34.97M155.37%21.07M116.01%5.82M19.11%-97.23M109.02%3.14M
Net non-operating interest income expense -9.65%6.59M-0.15%7.47M-2.57%7.42M31.10%29.66M-3.07%7.29M8.26%7.3M54.59%7.48M116.00%7.62M333.33%22.62M176.54%7.52M
Non-operating interest income -9.65%6.59M-0.15%7.47M----31.10%29.66M--7.29M--7.3M54.59%7.48M116.00%7.62M333.33%22.62M----
Total other finance cost --------2.57%-7.42M---------8.84%-7.34M-------7.62M--------
Other net income (expense) -142.86%-37.5M0-112.50%-12.5M-12.5M0.00%-12.5M450.00%87.5M0
Special income (charges) --0--0--0-142.86%-37.5M--0-112.50%-12.5M---12.5M0.00%-12.5M450.00%87.5M--0
-Less:Other special charges ------------142.86%37.5M--0112.50%12.5M--12.5M0.00%12.5M-450.00%-87.5M--0
Income before tax 61.13%47.97M191.52%46.78M4,577.79%43.6M639.37%95.36M356.13%48.61M-63.13%29.77M148.31%16.05M102.06%932K109.21%12.9M133.25%10.66M
Income tax -1,312.75%-31.4M1,669.81%8.44M7.86M215.37%6.2M59.34%3.13M2.59M477K01.97M1.97M
Net income 192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M
Net income continuous Operations 192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M
Minority interest income
Net income attributable to the parent company 192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M
Basic earnings per share 188.42%2.74146.30%1.334,033.33%1.24680.00%3.12393.75%1.58-67.01%0.95143.20%0.54101.70%0.03107.29%0.4125.60%0.32
Diluted earnings per share 192.31%2.66143.40%1.293,900.00%1.2669.23%3390.32%1.52-67.38%0.91142.40%0.53101.70%0.03107.10%0.39124.80%0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.89%
Sample Name
Sample Code
 +1.97%
4
Netflix
NFLX
+1.86%
5
NVIDIA
NVDA
+1.55%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.33%
Sample Name
Sample Code
 +8.72%
Sample Name
Sample Code
 +4.19%
4
KE Holdings
BEKE
+4.10%
5
Pony AI
PONY
+3.91%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -